The EIT Health Pitch Day marked the end of this year’s EIT Health Validation Lab, and sent 17 early-stage MedTech startups into the market. The event was held entirely online on October 27 and gave teams a chance to pitch their innovation to our network. Lifelet Medical took the coveted first prize.
“The Validation Lab was a great experience for Lifelet Medical, where we received excellent domain-specific mentorship and coaching. It was an honor to work with all of the startups, and we are delighted for the opportunity to advance to the central pitch competition and to accelerate our technology further”, says Elle Sander, co-founder of Lifelet Medical.
A partnership between EIT Health & YES!Delft
EIT Health Validation Lab is a partnership between YES!Delft and EIT Health. The two organizations join forces to offer early-stage companies an opportunity to validate their technology as best as possible, and combine YES!Delft’s startup expertise with the extensive knowledge and network of EIT Health.
Over the course of eight weeks, the two parties provided the right tooling and coaching to startups to develop their skills to validate their riskiest business assumptions, to sharpen their problem-solution-fit, and find their product-market-fit. The Validation Lab is designed to help promising MedTech teams get in touch with mentors and industry specialists already early on.
Solving a severe and relevant problem
Lifelet Medical, the winner of this edition, is on an ambitious yet very important mission. The team aims to improve the lives of patients with heart valve disease by developing fully synthetic durable and sustainable heart valve leaflets for life.
“Lifelet is solving a severe problem that is very relevant worldwide, they have a unique innovation and an excellent team,” said Evert Jaap Lugt, Managing Director of YES!Delft, when he announced the startup as the winner.
“We would like to thank all the startups and ecosystem partners for their ongoing enthusiasm throughout the program. I’m very curious to see what the future holds for these game-changers, I have very high expectations after everything we’ve seen so far”, says MedTech Program Manager, Claire Visser.